Share this Post!

In the interest of service and due to the continuing Public Health Emergency of International Concern, the effectivity of FDA Circular No. 2020-020, entitled “Interim Guidelines Governing the Issuance of a Permit to Register to Drug Importers for Foreign Drug Manufacturers” is hereby amended and extended until international travels return to normal unless sooner revoked.